Regulatory Exclusivity Reform in the 115th Congress
Full report
What this is
The Congressional Research Service is a nonpartisan policy and legal analysis arm of the Library of Congress. CRS reports are written for members of Congress and their staff, not the public — but they’re made available openly through Congress.gov.
- HR 5573114th Congress
PRICED Act
Jun 23, 2016 · Referred to the House Committee on Energy and Commerce.
- HR 1776115th Congress
Improving Access To Affordable Prescription Drugs Act
Apr 5, 2017 · Referred to the Subcommittee on Health.
- HR 2025115th Congress
Abuse-Deterrent Opioids Plan for Tomorrow Act of 2017
Apr 7, 2017 · Referred to the Subcommittee on Health.
- HR 2430115th Congress
FDA Reauthorization Act of 2017
Aug 18, 2017 · Signed by President.
- S 1509115th Congress
Orphan Products Extension Now Accelerating Cures and Treatments Act of 2017
Jun 29, 2017 · Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- S 771115th Congress
Improving Access To Affordable Prescription Drugs Act
Mar 29, 2017 · Read twice and referred to the Committee on Finance.
- S 934115th Congress
FDA Reauthorization Act of 2017
May 11, 2017 · Placed on Senate Legislative Calendar under General Orders. Calendar No. 76.
- HR 523897th Congress
Orphan Drug Act
Jan 4, 1983 · Became Public Law No: 97-414.